Stereoselectivity of actions of the calcium sensitizer [+]-EMD 60263 and its enantiomer [-]-EMD 60264

被引:13
作者
Ravens, U
Fluss, MO
Li, Q
Himmel, HM
Wettwer, E
Klockow, M
Lues, I
机构
[1] QUEENS UNIV, DEPT PHYSIOL, KINGSTON, ON K7L 3N6, CANADA
[2] MERCK KGAA, BIOMED FORSCH, D-64271 DARMSTADT, GERMANY
关键词
Ca2+-sensitizing action; stereoselectivity; positive inotropic effect; action potential prolongation; delayed rectifier current; I-Kr block; guinea pig cardiac myocytes;
D O I
10.1007/PL00005007
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The thiadiazinone derivative [+]-EMD 60263 ((+)-5-(1-(alpha-ethylimino-3,4-dimethoxybenzyl)-1,2,3,4-tetrahydroquinoline-6-yl)-6-methyl-3,6-dihydro- 2H-1,3,4-thiadiazine-2-on) is a Ca2+-sensitizing agent with only minor phosphodiesterase inhibitory activity. Our aim was to characterize the inotropic and electrophysiological effects of [+]-EMD 60263 and its enantiomer [-]-EMD 60264 in several cardiac muscle preparations. The Ca2+-sensitizing activity resided in the [+]-enantiomer only. [+]EMD 60263 (3 mu M) shifted the ECS, of Ca2+ for contractile activation of skinned fibers of pig heart from 2.41 mu M to 0.73 mu M, whereas [-]-EMD 60264 (30 mu M) was ineffective. In Langendorff-perfused guinea pig hearts, [+]-EMD 60263 and [-]-EMD 60264 induced concentration-dependent positive and negative inotropic effects, respectively; both enantiomers reduced spontaneous heart rate but did not influence perfusion pressure. The maximum increase in force of human atrial trabeculae was 35 % of pre-drug control with [+]-EMD 60263 in comparison to 113 % with forskolin. In guineapig papillary muscles, [+]-EMD 60263 and [-]-EMD 60264 had opposite inotropic responses, however, both agents similarly prolonged action potential duration. Both enantiomers concentration-dependently blocked the rapidly activating component IK, Of the delayed rectifier in guinea-pig myocytes. The block saturated at potentials positive to +30 mV, closely resembling the effects of the antiarrhythmic agent E-4031 which had been originally used to define I-Kr. It is concluded, that the positive inotropic action of [+]-EMD 60263 can be explained by prevalence of the Ca2+-sensitizing effect. The accompanying prolongation in action potential duration is caused by block of the I-Kr component of the delayed rectifier. While the inotropic effects are stereoselective, most of the electrophysiological actions are clearly independent of sterical configuration. The combination of Ca2+-sensitizing with class-III antiarrhythmic action may provide an interesting pharmacological profile of potential therapeutic use.
引用
收藏
页码:733 / 742
页数:10
相关论文
共 42 条
[1]   THE NOVEL CARDIOTONIC AGENT EMD-53-998 IS A POTENT CALCIUM SENSITIZER [J].
BEIER, N ;
HARTING, J ;
JONAS, R ;
KLOCKOW, M ;
LUES, I ;
HAEUSLER, G .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1991, 18 (01) :17-27
[2]  
BLINKS JR, 1986, CIRCULATION, V73, P85
[3]   SPONTANEOUS CA-2+ RELEASE FROM THE SARCOPLASMIC-RETICULUM LIMITS CA-2+-DEPENDENT TWITCH POTENTIATION IN INDIVIDUAL CARDIAC MYOCYTES - A MECHANISM FOR MAXIMUM INOTROPY IN THE MYOCARDIUM [J].
CAPOGROSSI, MC ;
STERN, MD ;
SPURGEON, HA ;
LAKATTA, EG .
JOURNAL OF GENERAL PHYSIOLOGY, 1988, 91 (01) :133-155
[4]   SYNCHRONOUS OCCURRENCE OF SPONTANEOUS LOCALIZED CALCIUM RELEASE FROM THE SARCOPLASMIC-RETICULUM GENERATES ACTION-POTENTIALS IN RAT CARDIAC VENTRICULAR MYOCYTES AT NORMAL RESTING MEMBRANE-POTENTIAL [J].
CAPOGROSSI, MC ;
HOUSER, SR ;
BAHINSKI, A ;
LAKATTA, EG .
CIRCULATION RESEARCH, 1987, 61 (04) :498-503
[5]   PROLONGED ACTION-POTENTIAL DURATION AND POSITIVE INOTROPY INDUCED BY THE NOVEL CLASS-III ANTIARRHYTHMIC AGENT H-234/09 (ALMOKALANT) IN ISOLATED HUMAN VENTRICULAR MUSCLE [J].
CARLSSON, L ;
ABRAHAMSSON, C ;
ALMGREN, O ;
LUNDBERG, C ;
DUKER, G .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1991, 18 (06) :882-887
[6]   NEW POSITIVE INOTROPIC AGENTS IN THE TREATMENT OF CONGESTIVE-HEART-FAILURE - MECHANISMS OF ACTION AND RECENT CLINICAL DEVELOPMENTS .2. [J].
COLUCCI, WS ;
WRIGHT, RF ;
BRAUNWALD, E .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (06) :349-358
[7]   NEW POSITIVE INOTROPIC AGENTS IN THE TREATMENT OF CONGESTIVE-HEART-FAILURE - MECHANISMS OF ACTION AND RECENT CLINICAL DEVELOPMENTS .1. [J].
COLUCCI, WS ;
WRIGHT, RF ;
BRAUNWALD, E .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (05) :290-299
[8]   PHOSPHODIESTERASE-III INHIBITORS - LONG-TERM RISKS AND SHORT-TERM BENEFITS [J].
CRUICKSHANK, JM .
CARDIOVASCULAR DRUGS AND THERAPY, 1993, 7 (04) :655-660
[9]   ON THE REVERSAL OF MYOCARDIAL STUNNING - A ROLE FOR CA2+-SENSITIZERS [J].
FAN, DS ;
SOEI, LK ;
SASSEN, LMA ;
KRAMS, R ;
HENDRIK, E ;
VERDOUW, PD .
CELLULAR, BIOCHEMICAL, AND MOLECULAR ASPECTS OF REPERFUSION INJURY, 1994, 723 :364-367
[10]   CURRENT STATUS OF PHOSPHODIESTERASE INHIBITORS IN THE TREATMENT OF CONGESTIVE-HEART-FAILURE [J].
FISCHER, TA ;
ERBEL, R ;
TREESE, N .
DRUGS, 1992, 44 (06) :928-945